{"id":404865,"date":"2024-06-14T09:46:16","date_gmt":"2024-06-14T15:46:16","guid":{"rendered":"https:\/\/billieparkernoticias.com\/?p=404865"},"modified":"2024-06-14T09:46:16","modified_gmt":"2024-06-14T15:46:16","slug":"cofepris-autoriza-innovador-ensayo-clinico-para-tratamiento-de-higado-graso","status":"publish","type":"post","link":"https:\/\/fronteraveracruz.com\/?p=404865","title":{"rendered":"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso."},"content":{"rendered":"<ul>\n<li><strong>Evaluar\u00e1 seguridad, tolerabilidad y eficacia de nueva medicaci\u00f3n para reducir colesterol y triglic\u00e9ridos<\/strong><\/li>\n<li><strong>H\u00edgado graso est\u00e1 asociado a otros padecimientos metab\u00f3licos, como obesidad y diabetes, de alta prevalencia en M\u00e9xico<\/strong><\/li>\n<li><strong>En los \u00faltimos quince d\u00edas se autorizaron 35 ensayos cl\u00ednicos<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>14.06.2024 Ciudad de M\u00e9xico. &#8211; La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) autoriz\u00f3 un ensayo cl\u00ednico destinado a evaluar seguridad, tolerabilidad y eficacia de un tratamiento para personas con hipertrigliceridemia y enfermedad de h\u00edgado graso no alcoh\u00f3lico.<\/p>\n<p>El h\u00edgado graso no alcoh\u00f3lico es una de las enfermedades hep\u00e1ticas m\u00e1s comunes a nivel mundial. Con frecuencia, se asocia a otros padecimientos metab\u00f3licos, como la obesidad y la diabetes, condiciones con alta prevalencia en M\u00e9xico.<\/p>\n<p>El estudio de esta enfermedad es de gran importancia debido a que, actualmente, las opciones terap\u00e9uticas son limitadas y se basan en modificaciones de la dieta, el ejercicio y el abordaje de padecimientos como diabetes u obesidad, en caso de estar presentes. Adem\u00e1s, suele progresar de forma asintom\u00e1tica hasta desarrollar cirrosis (fibrosis del h\u00edgado), una enfermedad con alta morbimortalidad.<\/p>\n<p>El ensayo cl\u00ednico autorizado permitir\u00e1 determinar la seguridad y eficacia del medicamento en estudio. Se espera que su mecanismo de acci\u00f3n contribuya a reducir los niveles de colesterol total, colesterol LDL (lipoprote\u00edna de baja densidad, asociada a enfermedades cardiovasculares) y triglic\u00e9ridos en la sangre.<\/p>\n<p>Este ensayo forma parte de los 35 autorizados por Cofepris en los \u00faltimos quince d\u00edas, como se detalla en el\u00a0<u><em><a href=\"https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/921378\/Informe_Ampliaci_n_Terap_utica_31_mayo_2024.pdf\" target=\"_blank\" rel=\"noopener\">Informe quincenal de ampliaci\u00f3n terap\u00e9utica<\/a><\/em>.<\/u><\/p>\n<p>Entre los insumos para la salud reci\u00e9n registrados se incluyen 32 medicamentos y 220 dispositivos m\u00e9dicos, 72 de ellos dise\u00f1ados espec\u00edficamente para atenci\u00f3n m\u00e9dica, como cables gu\u00eda coronarios, lentes intraoculares y pr\u00f3tesis de rodilla.<\/p>\n<p>Adem\u00e1s, se aprobaron 60 dispositivos para diagn\u00f3stico, detecci\u00f3n o medici\u00f3n de enfermedades como zika, dengue, chikungunya, y virus como SARS-CoV-2, VIH y virus sincicial respiratorio.<\/p>\n<p>Tambi\u00e9n se expidieron registros para 87 equipos, como cunas de calor radiante, equipos de tomograf\u00eda, sistemas de rayos X, bombas de jeringa, ultrasonidos terap\u00e9uticos y unidades de anestesia. Asimismo, se autoriz\u00f3 un\u00a0<em>software<\/em>\u00a0como dispositivo m\u00e9dico: se trata de una aplicaci\u00f3n m\u00f3vil para automonitoreo del historial de fibrilaci\u00f3n auricular.<\/p>\n<p>Cofepris autoriz\u00f3 dichos insumos tras demostrar, mediante exhaustivos procesos de evaluaci\u00f3n, que cumplen los m\u00e1s altos est\u00e1ndares de seguridad, calidad y eficacia.<\/p>\n<p>La elaboraci\u00f3n y publicaci\u00f3n del\u00a0<em>Informe quincenal de ampliaci\u00f3n terap\u00e9utica<\/em>\u00a0es un ejercicio de transparencia de Cofepris hacia industrias reguladas y pacientes, lo que evidencia el compromiso de esta agencia con la salud y equidad en el acceso a tratamientos m\u00e9dicos seguros y eficaces para toda la poblaci\u00f3n.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Evaluar\u00e1 seguridad, tolerabilidad y eficacia de nueva medicaci\u00f3n para reducir colesterol y triglic\u00e9ridos H\u00edgado graso est\u00e1 asociado a otros padecimientos metab\u00f3licos, como obesidad y diabetes, de alta prevalencia en M\u00e9xico En los \u00faltimos quince d\u00edas se autorizaron 35 ensayos cl\u00ednicos &nbsp; 14.06.2024 Ciudad de M\u00e9xico. &#8211; La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios&#8230;<\/p>\n","protected":false},"author":1,"featured_media":404866,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[18,229],"tags":[1606,1618],"class_list":["post-404865","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-de-ultima-hora","category-salud","tag-higado-graso","tag-tratamiento"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso. - Frontera Veracruz<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fronteraveracruz.com\/?p=404865\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso. - Frontera Veracruz\" \/>\n<meta property=\"og:description\" content=\"Evaluar\u00e1 seguridad, tolerabilidad y eficacia de nueva medicaci\u00f3n para reducir colesterol y triglic\u00e9ridos H\u00edgado graso est\u00e1 asociado a otros padecimientos metab\u00f3licos, como obesidad y diabetes, de alta prevalencia en M\u00e9xico En los \u00faltimos quince d\u00edas se autorizaron 35 ensayos cl\u00ednicos &nbsp; 14.06.2024 Ciudad de M\u00e9xico. &#8211; La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fronteraveracruz.com\/?p=404865\" \/>\n<meta property=\"og:site_name\" content=\"Frontera Veracruz\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-14T15:46:16+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/person\\\/bcc4f8719847e210f67a9030f3486609\"},\"headline\":\"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso.\",\"datePublished\":\"2024-06-14T15:46:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865\"},\"wordCount\":485,\"publisher\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"H\u00edgado Graso\",\"Tratamiento\"],\"articleSection\":[\"Noticias de \u00faltima hora\",\"Salud\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865\",\"name\":\"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso. - Frontera Veracruz\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2024-06-14T15:46:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=404865#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/fronteraveracruz.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#website\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/\",\"name\":\"Frontera Veracruz\",\"description\":\"Noticias C\u00f3rdoba \u00b7 Orizaba \u00b7 Veracruz\",\"publisher\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fronteraveracruz.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\",\"name\":\"Frontera Veracruz\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logo-header.png\",\"contentUrl\":\"https:\\\/\\\/fronteraveracruz.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logo-header.png\",\"width\":600,\"height\":220,\"caption\":\"Frontera Veracruz\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/share\\\/1CtNrbq7Bz\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/person\\\/bcc4f8719847e210f67a9030f3486609\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/fronteraveracruz.com\"],\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso. - Frontera Veracruz","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fronteraveracruz.com\/?p=404865","og_locale":"es_MX","og_type":"article","og_title":"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso. - Frontera Veracruz","og_description":"Evaluar\u00e1 seguridad, tolerabilidad y eficacia de nueva medicaci\u00f3n para reducir colesterol y triglic\u00e9ridos H\u00edgado graso est\u00e1 asociado a otros padecimientos metab\u00f3licos, como obesidad y diabetes, de alta prevalencia en M\u00e9xico En los \u00faltimos quince d\u00edas se autorizaron 35 ensayos cl\u00ednicos &nbsp; 14.06.2024 Ciudad de M\u00e9xico. &#8211; La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios...","og_url":"https:\/\/fronteraveracruz.com\/?p=404865","og_site_name":"Frontera Veracruz","article_publisher":"https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/","article_published_time":"2024-06-14T15:46:16+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fronteraveracruz.com\/?p=404865#article","isPartOf":{"@id":"https:\/\/fronteraveracruz.com\/?p=404865"},"author":{"name":"admin","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/person\/bcc4f8719847e210f67a9030f3486609"},"headline":"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso.","datePublished":"2024-06-14T15:46:16+00:00","mainEntityOfPage":{"@id":"https:\/\/fronteraveracruz.com\/?p=404865"},"wordCount":485,"publisher":{"@id":"https:\/\/fronteraveracruz.com\/#organization"},"image":{"@id":"https:\/\/fronteraveracruz.com\/?p=404865#primaryimage"},"thumbnailUrl":"","keywords":["H\u00edgado Graso","Tratamiento"],"articleSection":["Noticias de \u00faltima hora","Salud"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/fronteraveracruz.com\/?p=404865","url":"https:\/\/fronteraveracruz.com\/?p=404865","name":"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso. - Frontera Veracruz","isPartOf":{"@id":"https:\/\/fronteraveracruz.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fronteraveracruz.com\/?p=404865#primaryimage"},"image":{"@id":"https:\/\/fronteraveracruz.com\/?p=404865#primaryimage"},"thumbnailUrl":"","datePublished":"2024-06-14T15:46:16+00:00","breadcrumb":{"@id":"https:\/\/fronteraveracruz.com\/?p=404865#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fronteraveracruz.com\/?p=404865"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fronteraveracruz.com\/?p=404865#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/fronteraveracruz.com\/?p=404865#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/fronteraveracruz.com\/"},{"@type":"ListItem","position":2,"name":"Cofepris autoriza innovador ensayo cl\u00ednico para tratamiento de h\u00edgado graso."}]},{"@type":"WebSite","@id":"https:\/\/fronteraveracruz.com\/#website","url":"https:\/\/fronteraveracruz.com\/","name":"Frontera Veracruz","description":"Noticias C\u00f3rdoba \u00b7 Orizaba \u00b7 Veracruz","publisher":{"@id":"https:\/\/fronteraveracruz.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fronteraveracruz.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/fronteraveracruz.com\/#organization","name":"Frontera Veracruz","url":"https:\/\/fronteraveracruz.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/logo\/image\/","url":"https:\/\/fronteraveracruz.com\/wp-content\/uploads\/2026\/06\/logo-header.png","contentUrl":"https:\/\/fronteraveracruz.com\/wp-content\/uploads\/2026\/06\/logo-header.png","width":600,"height":220,"caption":"Frontera Veracruz"},"image":{"@id":"https:\/\/fronteraveracruz.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/"]},{"@type":"Person","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/person\/bcc4f8719847e210f67a9030f3486609","name":"admin","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/fronteraveracruz.com"],"url":"https:\/\/fronteraveracruz.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts\/404865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=404865"}],"version-history":[{"count":0,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts\/404865\/revisions"}],"wp:attachment":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=404865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=404865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=404865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}